We are live on
!
Find out more
Mitsubishi UFJ Asset Management Portfolio holdings
AUM
$180B
1-Year Est. Return
37.51%
This Fund
S&P 500
This Quarter
Est. Return
-14.8%
1 Year Est. Return
+37.51%
3 Year Est. Return
+115.4%
5 Year Est. Return
+142.39%
10 Year Est. Return
+552.78%
AUM
$22.6B
AUM Growth
-$2.7B
(-11%)
Cap. Flow
+$1.7B
Cap. Flow
% of AUM
7.5%
Top 10 Holdings %
Top 10 Hldgs %
24.02%
Holding
1,237
New
86
Increased
776
Reduced
172
Closed
94
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$101M |
| 2 |
Microsoft
MSFT
|
+$86.9M |
| 3 |
Amazon
AMZN
|
+$54.8M |
| 4 |
Amgen
AMGN
|
+$37.8M |
| 5 |
Tesla
TSLA
|
+$35.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$26M |
| 2 |
AT&T
T
|
+$17.5M |
| 3 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$16.7M |
| 4 |
CERN
Cerner Corp
CERN
|
+$14.2M |
| 5 |
Baidu
BIDU
|
+$13.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.29% |
| 2 | Healthcare | 14.31% |
| 3 | Financials | 11.76% |
| 4 | Consumer Discretionary | 10.47% |
| 5 | Communication Services | 7.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1001
Blue Bird Corp
BLBD
$2.1B
| $284K | ﹤0.01% |
30,878
-5,667
| -16% | -$79.5K |
|
|
RNAM
1002
DELISTED
Avidity Biosciences
RNAM
| $284K | ﹤0.01% |
+19,555
| New | +$291K |
|
1003
Xencor
XNCR
$1.63B
| $284K | ﹤0.01% |
10,392
+2,214
| +27% | +$54.6K |
|
|
LAND
1004
Gladstone Land Corp
LAND
$354M
| $283K | ﹤0.01% |
12,774
| – | – |
|
|
CYBE
1005
DELISTED
Cyberoptics Corp
CYBE
| $281K | ﹤0.01% |
8,041
+1,666
| +26% | +$68.2K |
|
1006
Accuray
ARAY
$35.6M
| $274K | ﹤0.01% |
139,560
+11,585
| +9% | +$28.9K |
|
1007
Fate Therapeutics
FATE
$316M
| $274K | ﹤0.01% |
11,071
+5,511
| +99% | +$152K |
|
|
UHT
1008
Universal Health Realty Income Trust
UHT
$572M
| $274K | ﹤0.01% |
5,156
| – | – |
|
|
RMO
1009
DELISTED
Romeo Power, Inc.
RMO
| $269K | ﹤0.01% |
600,576
+355,855
| +145% | +$333K |
|
1010
Editas Medicine
EDIT
$452M
| $268K | ﹤0.01% |
22,660
+13,721
| +153% | +$184K |
|
1011
Sarepta Therapeutics
SRPT
$1.89B
| $268K | ﹤0.01% |
3,580
-356
| -9% | -$26.2K |
|
1012
CRISPR Therapeutics
CRSP
$5.18B
| $266K | ﹤0.01% |
4,376
+609
| +16% | +$35.8K |
|
|
SGMO
1013
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $260K | ﹤0.01% |
62,874
+29,131
| +86% | +$126K |
|
1014
Intellia Therapeutics
NTLA
$1.68B
| $259K | ﹤0.01% |
4,996
+2,724
| +120% | +$138K |
|
|
CBL
1015
CBL Properties
CBL
$1.75B
| $255K | ﹤0.01% |
10,839
| – | – |
|
1016
Vir Biotechnology
VIR
$1.51B
| $253K | ﹤0.01% |
9,943
-40
| -0.4% | -$934 |
|
1017
Ocugen
OCGN
$451M
| $251K | ﹤0.01% |
+110,672
| New | +$265K |
|
1018
Arrowhead Research
ARWR
$12.6B
| $250K | ﹤0.01% |
7,088
+2,769
| +64% | +$104K |
|
1019
Codexis
CDXS
$161M
| $248K | ﹤0.01% |
23,685
+15,202
| +179% | +$191K |
|
|
CIO
1020
DELISTED
City Office REIT
CIO
| $247K | ﹤0.01% |
19,045
| – | – |
|
|
BFS
1021
Saul Centers
BFS
$851M
| $245K | ﹤0.01% |
5,198
| – | – |
|
1022
Immersion
IMMR
$251M
| $244K | ﹤0.01% |
45,612
-43,858
| -49% | -$227K |
|
1023
Vontier
VNT
$4.65B
| $243K | ﹤0.01% |
10,560
| – | – |
|
1024
Xos
XOS
$36.9M
| $243K | ﹤0.01% |
+4,409
| New | +$352K |
|
1025
IDEAYA Biosciences
IDYA
$3.57B
| $238K | ﹤0.01% |
17,270
+6,854
| +66% | +$76.2K |
|
Similar funds
VGA
Mitsubishi UFJ Asset Management's Q2 2022 Portfolio in Review
As of Q2 2022, Mitsubishi UFJ Asset Management held 1,237 positions worth $22.6B, down 11% from $25.3B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Mitsubishi UFJ Asset Management deployed $1.7B of net new capital in Q2 2022, opening 86 new positions and adding to 776 existing holdings. Its largest new stake was GitLab: 132,000 shares worth $7.01M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $26M trimmed.
- Mitsubishi UFJ Asset Management's largest Q2 2022 buy was GitLab: 132,000 shares worth $7.01M.
- Mitsubishi UFJ Asset Management added most to Apple in Q2 2022, an estimated $101M increase.
- Mitsubishi UFJ Asset Management's biggest Q2 2022 reduction was Vanguard S&P 500 ETF, cutting an estimated $26M.
- Mitsubishi UFJ Asset Management fully exited Cerner Corp in Q2 2022, selling an estimated $14.2M.
- Mitsubishi UFJ Asset Management's ten largest holdings make up 24% of its $22.6B portfolio in Q2 2022.
- Mitsubishi UFJ Asset Management opened 86 new positions and closed 94 in Q2 2022.
- Mitsubishi UFJ Asset Management's portfolio value fell 11% quarter-over-quarter to $22.6B.
Based on Mitsubishi UFJ Asset Management's 13F filing for Q2 2022, filed 4 Aug 2022.